April 25, 2017
Partner and drug regulatory expert Eileen McMahon was interviewed by Bloomberg to elucidate the federal government’s recent cannabis legalization bill. Eileen covered a broad range of subjects concerning the recently released legislation including:
When questioned about the dangers of leaving the majority of regulatory matters to provinces and the chances of a discordant, “patch-work” system, Eileen shared that ultimately “companies that are comfortable with a regulatory burden […] those companies will thrive. […] It’s clear that we’re moving to a state where we will not have prohibition but we will have a controlled regulated environment in Canada for cannabis.”
To learn more about Eileen’s insights to the growing cannabis industry and subsequent regulatory issues, click here.